Michael Snider, PhD

Dr. Snider brings to the CRF over 25 years of experience working in the biomedical research and with the pharmaceutical industry.  Dr. Snider has worked for several companies during his career, including positions with T Cell Sciences, Pfizer, Burroughs-Wellcome, and Berlex Biosciences, for whom he was Scientific Director of Molecular Pharmacology.  Dr. Snider brings experience with drug development, having been involved with the development of 10 projects in Clinical Development phase and 3 having achieved marketed drug status.  Dr. Snider is extensively published, with over 60 articles in scientific journals during his career.

News and Updates

Sign up to keep updated on the latest news, events, and research.

Tell Your Friends About Choroideremia

The Choroideremia Research Foundation Inc. is an international, non-profit organization dedicated to raising funds to find a treatment or cure for Choroideremia, a rare inherited retinal degenerative disease that causes blindness.

Copyright © 2017 The Choroideremia Research Foundation Inc.

The Choroideremia Research Foundation takes seriously our responsibility to maintain your privacy in all matters related to the Foundation. Specifically, we do not sell, rent or otherwise distribute to any individual or organization names, addresses or other information we receive through our newsletter, our website or other forms of digital or written communication.